Trileptal Related Published Studies
Well-designed clinical trials related to Trileptal (Oxcarbazepine)
Comparative efficacy and safety of oxcarbazepine versus divalproex sodium in the treatment of acute mania: a pilot study. [2009.04]
Effect of Oxcarbazepine in the Treatment of Agitation and Aggression in Severe Dementia. [2009.02.02]
Bipolar I and II disorder residual symptoms: Oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial. [2009.02.01]
Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia. [2009]
Bioequivalence of oxcarbazepine oral suspension vs. film-coated tablet in healthy Chinese male subjects. [2008.10]
A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder. [2008.06]
A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder. [2008.03.17]
Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study. [2008.02.12]
Parent drug and/or metabolite? Which of them is most appropriate to establish bioequivalence of two oral oxcarbazepine formulations in healthy volunteers? [2007.07]
Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study. [2007.07]
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. [2007.03.24]
Diagnostics for confounding in PK/PD models for oxcarbazepine. [2007.01.30]
Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy. [2006.12.26]
A pilot clinical trial of oxcarbazepine in adults with attention-deficit hyperactivity disorder. [2006.08.30]
Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures. [2006.08.22]
A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. [2006.07]
Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study. [2006.06]
Oxcarbazepine versus phenytoin monotherapy for epilepsy. [2006.04.19]
Diagnostics for confounding in PK/PD models for oxcarbazepine. [2006.04.13]
A pilot study of oxcarbazepine versus acamprosate in alcohol-dependent patients. [2006.04]
Oxcarbazepine in patients with impulsive aggression: a double-blind, placebo-controlled trial. [2005.12]
Lack of pharmacokinetic interaction between oxcarbazepine and lamotrigine. [2005.12]
Oxcarbazepine as add-on therapy in Thai epileptic patients with refractory partial seizures. [2005.11]
Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. [2005.10]
Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers. [2004.12]
Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy. [2004.11]
Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers. [2004.11]
Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch. [2004.06]
Efficacy of oxcarbazepine in the treatment of painful diabetic neuropathy. [2004.05]
Sustained efficacy and long-term safety of oxcarbazepine: one-year open-label extension of a study in refractory partial epilepsy. [2003.09]
Pharmacokinetic drug interactions in children taking oxcarbazepine. [2003.08]
Assessment of the bioequivalence of two oxcarbazepine oral suspensions versus a film-coated tablet in healthy subjects. [2003.07]
Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. [2003.04]
Oxcarbazepine final market image tablet formulation bioequivalence study after single administration and at steady state in healthy subjects. [2002.11]
Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures. [2001.09.11]
Oxcarbazepine, an antiepileptic agent. [2001.05]
Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. [2000.12]
Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial. [2000.06.27]
Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group. [2000.06.27]
Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women. [1999.06]
Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. [1999.03.10]
A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. [1997.06]
A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. [1997.06]
A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. [1997.03]
Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepine. [1995.10]
The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers. [1994.08]
Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy. [1994.08]
A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients. [1994.01]
The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid. [1993.10]
Absence of interaction between oxcarbazepine and erythromycin. [1992.08]
Effects of oxcarbazepine and carbamazepine on the central nervous system: computerised analysis of saccadic and smooth-pursuit eye movements. [1992.06]
Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up. [1992.05]
Oxcarbazepine does not interact with cimetidine in healthy volunteers. [1992.04]
A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. [1989.01]
Oxcarbazepine (GP 47.680): a possible alternative to carbamazepine? [1987.11]
Well-designed clinical trials possibly related to Trileptal (Oxcarbazepine)
Levetiracetam in patients with impulsive aggression: a double-blind, placebo-controlled trial. [2008.02]
Erythrocyte and plasma fatty acid profiles in patients with epilepsy: does carbamazepine affect omega-3 fatty acid concentrations? [2008.02]
Management of neuropathic pain. [2007.08]
Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs. [2007.07]
How reliable is early treatment response in predicting long-term seizure outcome? [2007.06]
Seizure-Free Outcome in Randomized Add-on Trials of the New Antiepileptic Drugs. [2007.05.23]
ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. [2006.07]
[Use of antiepileptic drugs in bipolar disorder] [2006.01]
Safety, tolerability, and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic, in a rising multiple-dose study in young healthy humans. [2004.08]
Safety, tolerability and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic agent, during first administration to humans. [2003]
Other research related to Trileptal (Oxcarbazepine)
Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures. [2009.10.07]
Oxcarbazepine in combination with Tiaprid in inpatient alcohol-withdrawal--a RCT. [2009.09]
The effect of oxcarbazepine on bone metabolism. [2009.09]
Effect of oxcarbazepine on sleep architecture. [2009.07]
The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine. [2009.05.06]
Oxcarbazepine treatment of restless legs syndrome: three case reports. [2009.05]
[Primary erythermalgia: efficacy of oxcarbazepine] [2009.04]
Oxcarbazepine use in paroxysmal kinesigenic dyskinesia: report on four patients. [2009.04]
Seizure deterioration in women treated with oxcarbazepine during pregnancy. [2009.04]
Oxcarbazepine treatment in male epilepsy patients improves pre-existing sexual dysfunction. [2009.02]
Oxcarbazepine-induced Stevens-Johnson syndrome: a case report. [2009.02]
Oxcarbazepine, not its active metabolite, potentiates GABAA activation and aggravates absence seizures. [2009.01]
Oxcarbazepine for refractory epilepsy: systematic review of the literature. [2009]
Impact of efflux transporters and of seizures on the pharmacokinetics of oxcarbazepine metabolite in the rat brain. [2008.12]
Oxcarbazepine-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). [2008.12]
Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy. [2008.11]
Bioequivalence of oxcarbazepine oral suspension vs. film-coated tablet in healthy Chinese male subjects. [2008.10]
Overnight transition from carbamazepine to oxcarbazepine in children and adolescents. [2008.10]
Evaluation of bone turnover in epileptic children using oxcarbazepine. [2008.10]
Neuroleptic malignant syndrome without fever after addition of oxcarbazepine to long-term treatment with amisulpride. [2008.09]
Efficiency and safety of oxcarbazepine in mood disorders: a naturalistic study exploring the interest of plasma dosages. [2008.09]
Effects of chronic treatment with valproate and oxcarbazepine on ovarian folliculogenesis in rats. [2008.07]
Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy. [2008.07]
Oxcarbazepine for the treatment of binge eating disorder: a case series. [2008.07]
An oxcarbazepine-related fatality with an overview of 26 oxcarbazepine postmortem cases. [2008.05.20]
Long-term assessment of oxcarbazepine in a naturalistic setting: a retrospective study. [2008.05]
Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia. [2008.05]
Giant hepatic adenoma with atypical features in a patient on oxcarbazepine therapy. [2008.04]
Oxcarbazepine may induce psychotic symptoms in Parkinson's disease. [2008.04]
[Rapid inpatient tramadol-detoxification using oxcarbazepine] [2008.04]
Oxcarbazepine and adverse events: impact of age, dosage, metabolite serum concentrations and concomitant antiepileptic therapy. [2008.04]
Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy. [2008.03]
Oxcarbazepine-induced hemolytic anemia in a geriatric patient. [2008.03]
Temporal pattern of oxcarbazepine and phenytoin withdrawal seizures during epilepsy monitoring. [2008.03]
Comparison of carbamazepine and oxcarbazepine effects on aminothiol levels. [2008.01]
Interactions of MRZ 2/576 with felbamate, lamotrigine, oxcarbazepine and topiramate in the mouse maximal electroshock-induced seizure model. [2008]
|
